REVALESIO

Revalesio is a clinical-stage pharmaceutical company with a vision to develop safer and more effective treatments for people with an acute ischemic stroke and other neurological conditions. Our pioneering science addresses fundamental disease mechanisms to improve recovery and reduce disability in stroke and slow disease progression in chronic neurological conditions, aiming to make meaningful improvements in the quality of life of individuals who currently have few therapeutic treatment options... Our technology platform utilizes fluid dynamics (specifically Taylor-Couette-Poiseuille [TCP] flow) to generate therapeutics. The goal of this unique application of physics is to produce drugs that protect cells from acute injury and correct the foundational imbalances that contribute to the progressive nature of many neurological conditions, specifically mitochondrial dysfunction and inflammation. Because these imbalances underlie many different diseases, we believe our platform will have..

Also known as: Revalesio Corporation

Primary location: Tacoma United States